186 related articles for article (PubMed ID: 8139043)
1. Negative regulation of the 5' long terminal repeat (LTR) by the 3' LTR in the murine proviral genome.
Gama Sosa MA; Rosas DH; DeGasperi R; Morita E; Hutchison MR; Ruprecht RM
J Virol; 1994 Apr; 68(4):2662-70. PubMed ID: 8139043
[TBL] [Abstract][Full Text] [Related]
2. Rat cellular mutants for expression of mRNA from the long terminal repeat of murine retrovirus.
Isaka M; Inoue H; Tsukiyama T; Niwa O; Hakura A
Virology; 1992 Jul; 189(1):141-9. PubMed ID: 1604805
[TBL] [Abstract][Full Text] [Related]
3. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.
Ch'ang LY; Yang WK; Myer FE; Yang DM
J Virol; 1989 Jun; 63(6):2746-57. PubMed ID: 2542587
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position.
Hoeben RC; Migchielsen AA; van der Jagt RC; van Ormondt H; van der Eb AJ
J Virol; 1991 Feb; 65(2):904-12. PubMed ID: 1702844
[TBL] [Abstract][Full Text] [Related]
5. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
[TBL] [Abstract][Full Text] [Related]
6. A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes.
Choi SY; Faller DV
J Virol; 1995 Nov; 69(11):7054-60. PubMed ID: 7474125
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the binding proteins and activity of the long terminal repeat of Moloney murine leukemia virus during differentiation of mouse embryonal carcinoma cells.
Tsukiyama T; Niwa O; Yokoro K
J Virol; 1991 Jun; 65(6):2979-86. PubMed ID: 2033663
[TBL] [Abstract][Full Text] [Related]
8. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.
Faller DV; Weng H; Choi SY
Virology; 1997 Jan; 227(2):331-42. PubMed ID: 9018132
[TBL] [Abstract][Full Text] [Related]
9. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
Feuer G; Fan H
J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
[TBL] [Abstract][Full Text] [Related]
10. Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.
Overhauser J; Fan H
J Virol; 1985 Apr; 54(1):133-44. PubMed ID: 2983110
[TBL] [Abstract][Full Text] [Related]
11. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U; Böhnlein E; Veres G
Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
[TBL] [Abstract][Full Text] [Related]
12. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H; Mittal S; Chute H; Chao E; Pattengale PK
J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
[TBL] [Abstract][Full Text] [Related]
13. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
Brightman BK; Farmer C; Fan H
J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
[TBL] [Abstract][Full Text] [Related]
14. Expression of phosphoenolpyruvate carboxykinase (PEPCK) chimeras in renal epithelial cells. Retention of appropriate physiological responsiveness using enhancerless retroviral vectors.
Pollock AS; Lovett DH
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):725-32. PubMed ID: 1377912
[TBL] [Abstract][Full Text] [Related]
15. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
16. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.
Rettinger SD; Kennedy SC; Wu X; Saylors RL; Hafenrichter DG; Flye MW; Ponder KP
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1460-4. PubMed ID: 8108431
[TBL] [Abstract][Full Text] [Related]
17. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Couture LA; Mullen CA; Morgan RA
Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional interaction between retroviral long terminal repeats (LTRs): mechanism of 5' LTR suppression and 3' LTR promoter activation of c-myc in avian B-cell lymphomas.
Boerkoel CF; Kung HJ
J Virol; 1992 Aug; 66(8):4814-23. PubMed ID: 1321271
[TBL] [Abstract][Full Text] [Related]
19. Identification of sequences in the long terminal repeat of the lymphoproliferative disease virus required for efficient transcription.
Sarid R; Gazit A; Tronick SR; Yaniv A
Virology; 1995 Apr; 208(2):789-94. PubMed ID: 7747452
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the rous sarcoma virus long terminal repeat-driven transcription by in vitro methylation: different sensitivity in permissive chicken cells versus mammalian cells.
Hejnar J; Plachý J; Geryk J; Machon O; Trejbalová K; Guntaka RV; Svoboda J
Virology; 1999 Mar; 255(1):171-81. PubMed ID: 10049832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
